A 32-year-old woman on combined oral contraceptives (35 µg ethinyl estradiol + norethisterone) for 5 years presents with a 2-month history of severe headaches with visual disturbances (scotomata) occurring 2–3 times per week. Neurological examination is otherwise normal. Blood pressure is 128/82 mmHg. What is the most appropriate next step in management?

Explanation

## Migraine with Aura and Combined Oral Contraceptives ### Clinical Significance This patient presents with **migraine with aura** (visual scotomata are classic aura symptoms) while on a combined oral contraceptive. This combination carries a significantly elevated risk of ischemic stroke. ### Pathophysiology & Risk **Key Point:** - **Migraine with aura** is an independent risk factor for ischemic stroke (RR ~2–4). - **Combined OCPs** increase stroke risk (RR ~3–4), particularly with estrogen doses ≥50 µg. - **The combination of migraine with aura + OCP = synergistic risk**, with RR approaching 8–10 for ischemic stroke. - This risk is driven by: - Estrogen-induced hypercoagulability (increased factors V, VII, X; decreased protein S) - Endothelial dysfunction and vasospasm triggered by migraine aura - Platelet aggregation enhancement ### WHO Medical Eligibility Criteria (MEC) Classification | Contraceptive Method | Migraine without Aura | Migraine with Aura | |---|---|---| | **Combined OCP (estrogen-containing)** | Category 2 (generally acceptable) | **Category 4 (CONTRAINDICATED)** | | **Progestin-only pill (POP)** | Category 1 (no restriction) | Category 1 (no restriction) | | **Progestin-only injectable (DMPA)** | Category 1 | Category 1 | | **Levonorgestrel IUD** | Category 1 | Category 1 | | **Copper IUD** | Category 1 | Category 1 | **High-Yield:** - **Migraine WITH aura = absolute contraindication to estrogen-containing contraceptives** (WHO Category 4). - **Migraine WITHOUT aura = acceptable with combined OCP** (WHO Category 2, with counseling). ### Management Algorithm ```mermaid flowchart TD A[Woman on OCP with new headaches]:::outcome --> B{Migraine with aura?}:::decision B -->|No aura, no red flags| C[Continue OCP, counsel on warning signs]:::action B -->|Aura present OR red flags| D[STOP OCP immediately]:::urgent D --> E[Switch to progestin-only method]:::action E --> F[Refer to neurology if headaches persist]:::action A --> G{Red flags: focal neuro deficit, papilledema, fever?}:::decision G -->|Yes| H[Urgent imaging and neurology referral]:::urgent G -->|No| I[Reassess for aura symptoms]:::action ``` ### Red Flags for Stroke Risk (ACHES Mnemonic) **Mnemonic: ACHES** - **A** = Abdominal pain (severe, atypical) - **C** = Chest pain or dyspnea - **H** = Headache (new, severe, persistent, or change in pattern) **← THIS PATIENT** - **E** = Eye problems (visual loss, scotomata, diplopia) **← THIS PATIENT** - **S** = Severe leg pain or swelling Presence of any ACHES symptom warrants immediate OCP discontinuation and evaluation. ### Why Discontinuation is Urgent **Clinical Pearl:** - The patient has **two major components of the ACHES criteria: headache with visual disturbances (scotomata)**, which is pathognomonic for migraine with aura. - Continuing estrogen-containing contraception in this setting exposes her to unacceptable stroke risk. - The decision to stop is **not deferred pending neurology evaluation**—it is made immediately based on clinical presentation. - Neurology referral is appropriate for headache management and confirmation of migraine diagnosis, but it does NOT delay OCP discontinuation. ### Appropriate Next Steps 1. **Discontinue the OCP immediately** (do not wait for neurology). 2. **Switch to a progestin-only method:** - Progestin-only pill (POP; e.g., norethisterone 350 µg daily) - Progestin-only injectable (DMPA; medroxyprogesterone acetate 150 mg IM every 12 weeks) - Progestin-releasing IUD (levonorgestrel IUD; Mirena) - Implant (etonogestrel 68 mg subdermal rod) 3. **Refer to neurology** for: - Confirmation of migraine with aura diagnosis - Headache management (prophylactic agents if needed) - Exclusion of secondary causes (though normal neuro exam is reassuring) 4. **Counsel the patient** on: - Stroke risk factors and warning signs - Importance of adherence to progestin-only method - Lifestyle modifications (smoking cessation, blood pressure control) ### Why NOT the Other Options **Continuing OCP + triptan:** Triptans are vasoconstrictors and are contraindicated in migraine with aura due to additional stroke risk. Continuing estrogen-containing contraception is absolutely contraindicated regardless of acute headache management. **Urgent brain MRI:** While imaging may be appropriate if there are atypical features or focal neurological deficits, the clinical presentation is classic for migraine with aura. Normal neuro exam and typical symptom pattern do not mandate emergent imaging. Imaging should not delay OCP discontinuation. **Neurology referral before stopping OCP:** Neurology referral is appropriate and should be arranged, but it does NOT delay immediate OCP discontinuation. The contraindication is clear based on clinical presentation (migraine with aura + OCP = WHO Category 4). Waiting for neurology evaluation would inappropriately prolong exposure to stroke risk. **High-Yield:** - **Mnemonic: "Aura + OCP = STOP immediately"** — do not defer this decision pending specialist input. - The combination of migraine with aura and estrogen-containing contraception is one of the few absolute contraindications to OCP use in reproductive medicine.